Cardio Diagnostics Holdings, Inc. (CDIO)
1.925
-0.10
(-5.17%)
USD |
NASDAQ |
Aug 24, 16:00
1.97
+0.04
(+2.34%)
After-Hours: 20:00
Cardio Diagnostics Holdings Shareholders Equity (Quarterly) : 7.426M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.426M |
| March 31, 2026 | 8.903M |
| December 31, 2025 | 6.973M |
| September 30, 2025 | 8.152M |
| June 30, 2025 | 9.725M |
| March 31, 2025 | 11.38M |
| December 31, 2024 | 9.558M |
| September 30, 2024 | 3.686M |
| June 30, 2024 | 3.074M |
| March 31, 2024 | 3.037M |
| December 31, 2023 | 2.958M |
| Date | Value |
|---|---|
| September 30, 2023 | 2.288M |
| June 30, 2023 | 2.908M |
| March 31, 2023 | 3.422M |
| December 31, 2022 | 4.302M |
| September 30, 2022 | 65.17M |
| June 30, 2022 | 64.97M |
| March 31, 2022 | 65.46M |
| December 31, 2021 | 1.068M |
| September 30, 2021 | 0.0243M |
| June 30, 2021 | 0.0246M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 113.59M |
| Exicure, Inc. | 0.977M |
| Century Therapeutics, Inc. | 232.34M |
| Absci Corp. | 246.13M |
| Celularity, Inc. | -38.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.926M |
| Total Liabilities (Quarterly) | 0.4998M |
| Debt to Equity Ratio | 0.0498 |
| Current Ratio | 17.15 |
| Net Debt Paydown Yield | 1.32% |